Effect of oral micronized progesterone on androgen levels in women with polycystic ovary syndrome
Authors:
- Rosario ReynaRRRosario Reyna
- Ricardo AzzizRARicardo Azziz
- 1 June 2002
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 77 (6) , 1125-1127
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The time has come to simplify the evaluation of the hirsute patientFertility and Sterility, 2000
- Comparison of the pharmacokinetics of Crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal womenFertility and Sterility, 2000
- Screening for 21-hydroxylase–deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective studyFertility and Sterility, 1999
- Chronic hyperinsulinemia and the adrenal androgen response to acute corticotropin-(1–24) stimulation in hyperandrogenic womenAmerican Journal of Obstetrics and Gynecology, 1995
- Serum testosterone, androstenedione and luteinizing hormone levels after short‐term medroxyprogesterone acetate treatment in women with polycystic ovarian diseaseActa Obstetricia et Gynecologica Scandinavica, 1994
- Serum androgen and gonadotropin levels decline after progestogen-induced withdrawal bleeding in oligomenorrheic women with or without polycystic ovariesFertility and Sterility, 1992
- Changes in the concentration of testosterone in serum during the menstrual cycle, as determined by liquid chromatography.Clinical Chemistry, 1988
- Absorption and metabolism of oral progesterone.BMJ, 1980
- Ovarian and Adrenal Contribution to Peripheral Androgens During the Menstrual CycleThe Journal of Clinical Endocrinology & Metabolism, 1974
- Serum testosterone concentrations in women throughout the menstrual cycle and following HCG administrationAmerican Journal of Obstetrics and Gynecology, 1974